Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.

Keyphrases

• Immune Response 100%
• Leishmania 100%
• Hamster 100%
• Major Determinants 100%
• Clinical Evolution 100%
• Male Animals 100%
• Disease Severity 66%
• Lesion Size 66%
• Transforming Growth Factor-β 66%
• Gender Differences 66%
• Leishmania Infection 33%
• Leishmaniasis 33%
• Interleukin-10 33%
• Interleukin-4 (IL-4) 33%
• Human Disease 33%
• Cutaneous Leishmaniasis 33%
• Clinical Disease 33%
• Most Common Cause 33%
• Tumor-draining Lymph Nodes 33%
• Testosterone 33%
• Adult Male 33%
• Exposure Risk 33%
• Cutaneous Lesions 33%
• Large Lesions 33%
• Parasite Burden 33%
• Host Response to Infection 33%
• Cutaneous Infection 33%
• Lines of Evidence 33%
• P Factor 33%
• Sex Hormones 33%
• Intralesional 33%
• Inherent Risk 33%
• Two-line 33%
• Lesion Severity 33%
• Second Infection 33%
• Viannia 33%
• Disease Evolution 33%
• Male Hamster 33%
• Experimental Leishmaniasis 33%
• Spearman Correlation Coefficient 33%
• Chronic Lesions 33%
• Leishmania Viannia 33%
• Pre-pubertal Male 33%
• Hormone Status 33%

Immunology and Microbiology

• Immune Response 100%
• Leishmania 100%
• Infection 100%
• Leishmaniasis 50%
• Cancer Growth Factor 33%
• Cytokine 16%
• Cutaneous Leishmaniasis 16%
• Lymph Node 16%
• Interleukin 4 16%
• Interleukin 10 16%
• Parasite Load 16%
• Leishmania braziliensis 16%

Veterinary Science and Veterinary Medicine

• Infectious Disease 100%
• Leishmania 100%
• Diseases 85%
• Cancer Growth Factor 28%
• Leishmaniasis 28%
• Mouse 14%
• Cutaneous Lesion 14%
• Reproductive Hormone 14%
• Lymph Node 14%
• Cutaneous Leishmaniasis 14%